Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics/pharmacodynamics of voriconazole in critically ill patients
2009-016936-11Phase 4Active
- Sponsor
- Bellvitge University Hospital
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in Fungal lower respiratory tract infection (FLRTI), sponsored by Bellvitge University Hospital. Primary endpoint: Plasma voriconazole concentrations. Started Feb 2011; status: active.
02
Drugs
voriconazole
03
Conditions
Fungal lower respiratory tract infection (FLRTI)
Beyond the preview
Go deeper on 2009-016936-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016936-11.